Showing 281-290 of 2910 results for "".
About the Cover Artist: Le Bon, La Brute, Et Le Truand by JJ Ignatius Brennan
https://practicalneurology.com/diseases-diagnoses/headache-pain/about-the-cover-artist-ile-bon-la-brute-et-le-truandi-by-jj-ignatius-brennan/32137/The artwork of JJ Ignatius Brennan is informed by the visual disturbances and auras he experiences during migraine attacks.Practical Considerations for Family Planning in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/practical-considerations-for-family-planning-in-multiple-sclerosis/32086/Family planning is an integral part of comprehensive multiple sclerosis care for women of childbearing age.MELAS: A Tricky Disease with an Easy Diagnostic Test
https://practicalneurology.com/diseases-diagnoses/stroke/melas-a-tricky-disease-with-an-easy-diagnostic-test/30638/MELAS (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes) is a multisystem disorder with onset typically in childhood. Mutation in mitochondrial DNA gene MT-TL1 is cause of the disease in 80 percent.Medical Cannabis for Migraine & Pain
https://practicalneurology.com/diseases-diagnoses/headache-pain/medical-cannabis-for-migraine-pain/31783/Early evidence for cannabis to treat pain and migraine warrants further research.Friedreich Ataxia: Pathophysiology and Treatment
https://practicalneurology.com/diseases-diagnoses/movement-disorders/friedreich-ataxia-pathophysiology-and-treatment/32041/Great strides have been made in understanding the pathophysiology of Friedreich ataxia, and a variety of treatments are available, including the first drug approved for Friedreich ataxia treatment in 2023.Relapse Management in Multiple Sclerosis: Corticosteroids Remain the Linchpin of Therapies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapse-management-in-multiple-sclerosis-corticosteroids-remain-the-linchpin-of-therapies/32084/Several modalities are available for the treatment of multiple sclerosis relapse, including corticosteroids, intravenous immunoglobulins, and therapeutic apheresis.Neurologic Manifestations & Associations of COVID-19
https://practicalneurology.com/diseases-diagnoses/imaging-testing/neurologic-manifestations-associations-of-covid-19/31739/High-quality epidemiologic data is still urgently needed to better understand neurologic effects of COVID-19.Diagnostic Considerations for New-Onset Epilepsy in Older Adults
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/diagnostic-considerations-for-new-onset-epilepsy-in-older-adults/32175/Early recognition and accurate diagnosis by health care providers are key to the optimal management of the older adult with epilepsy.Resumption of Anticoagulant Therapy Following Ischemic and Hemorrhagic Strokes: Indications and Timing
https://practicalneurology.com/diseases-diagnoses/stroke/resumption-of-anticoagulant-therapy-following-ischemic-and-hemorrhagic-strokes-indications-and-timing/31965/Resumption of anticoagulant in ischemic stroke or intracranial hemorrhage should be individualized.Association of Lifestyle Factors with Cognition
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/association-of-lifestyle-factors-with-cognition/32012/Evidence supports the benefit of cognitive, social, physical, and multimodal interventions for people at different stages of cognitive and functional impairment.